| 1 |
Donald J. Barnickel |
AT&T |
9 |
| 2 |
Jeffrey M. Cogen |
Dow Global Technologies |
7 |
| 3 |
Rodrigo CEBALLOS LENTINI |
— |
6 |
| #4 |
Gennadiy Itov |
L'Air Liquide, Societe Anonyme Pour L'Etude Et L'Exploitation Des Procedes Georges Claude |
5 |
| #4 |
Julian Quintero |
Johnson & Johnson |
5 |
| #6 |
Arsam Behkish |
ExxonMobil |
4 |
| #7 |
Sean C. Ely |
Ingersoll-Rand |
3 |
| #7 |
Michael Berlin |
Arvinas Operations |
3 |
| #7 |
Derek Wade Ohlarik |
Verizon |
3 |
| #10 |
Daniel P. Leta |
ExxonMobil |
2 |
| #10 |
William M. Beckenbaugh |
Motorola |
2 |
| #10 |
Michael P. Lanci |
ExxonMobil |
2 |
| #10 |
Johnu Celestine |
Express Scripts Strategic Development |
2 |
| #10 |
Lyndsay Schaeffer-Korbylo |
Colgate-Palmolive |
2 |
| #10 |
Robert J Gibbs |
Fca Us Llc. |
2 |
| #10 |
Tarun Verma |
Verizon |
2 |
| #10 |
Zhisheng Gao |
ExxonMobil |
2 |
| #10 |
Matthew T. Kapelewski |
ExxonMobil |
2 |
| #10 |
Anthony S. Mennito |
ExxonMobil |
2 |
| #10 |
David T. Ferrughelli |
ExxonMobil |
2 |
| #21 |
James F. Mulvey |
Lockheed Martin |
1 |
| #21 |
Frank Rumore |
Go!Foton |
1 |
| #21 |
Jay D. Fischer |
— |
1 |
| #21 |
Dan V. Goia |
Umicore Ag & Co. Kg |
1 |
| #21 |
John Krupinski |
Bristol-Myers Squibb |
1 |
| #21 |
David L. Kimball |
Johnson & Johnson |
1 |
| #21 |
Christopher G. Levins |
MIT |
1 |
| #21 |
Kallan Kuper |
— |
1 |
| #21 |
Cynthia L. Cain |
Henkel Ip & Holding Gmbh |
1 |
| #21 |
Joseph E. Myers, Jr. |
Bristol-Myers Squibb |
1 |
| #21 |
Allen Keith On |
Johnson & Johnson |
1 |
| #21 |
Robert V. DeLuca |
Ericsson |
1 |
| #21 |
Walter A. Rice |
Oxy-Dry |
1 |
| #21 |
Machteld M. W. Mertens |
ExxonMobil |
1 |
| #21 |
Wu Suen |
Henkel Ip & Holding Gmbh |
1 |
| #21 |
Man Luo |
Beijing Dajia Internet Information Technology Co. |
1 |
| #21 |
Jason Healy |
Lexicon Pharmaceuticals |
1 |
| #21 |
Arkady RUBIN |
Arstat |
1 |
| #21 |
Kevin J. Klopfer |
Bristol-Myers Squibb |
1 |
| #21 |
Samuel J. Bonacorsi, Jr. |
Bristol-Myers Squibb |
1 |
| #21 |
Erik Gunderman |
— |
1 |
| #21 |
Daniel J. Taylor |
Microsoft |
1 |
| #21 |
Michael C. Hicks |
— |
1 |
| #21 |
Christopher W. Boyce |
Merck |
1 |
| #21 |
Raouf Ghaderi |
— |
1 |
| #21 |
Lawrence W. Thau, Jr. |
Victaulic |
1 |
| #21 |
Srdjan R. Stankovic |
Acadia Pharmaceuticals |
1 |
| #21 |
Justin P. Brandt |
Victaulic |
1 |
| #21 |
Panna Sanga |
Johnson & Johnson |
1 |
| #21 |
Steven Polston |
AT&T |
1 |